View in EDS

Discovery of novel 2,4-diarylaminopyrimidine derivatives as potent and selective epidermal growth factor receptor (EGFR) inhibitors against L858R/T790M resistance mutation.

Saved in:

Bibliographic Details
Title:	Discovery of novel 2,4-diarylaminopyrimidine derivatives as potent and selective epidermal growth factor receptor (EGFR) inhibitors against L858R/T790M resistance mutation.
Authors:	Yan, Qi¹, Chen, Yuzhe^2,3, Tang, Baiyou^2,4, Xiao, Qiang¹, Qu, Rong^2,3, Tong, Linjiang², Liu, Jian¹, Ding, Jian², Chen, Yi², Ding, Ning¹, Tan, Wenfu¹ wftan@fudan.edu.cn, Xie, Hua² hxie@simm.ac.cn, Li, Yingxia¹ liyx417@fudan.edu.cn
Source:	European Journal of Medicinal Chemistry. May2018, Vol. 152, p298-306. 9p.
Database:	Academic Search Ultimate

Description
ISSN:	02235234
DOI:	10.1016/j.ejmech.2018.04.052